Therapeutic option for R/R mature T- and NK-cell neoplasms

Emmanuel Bachy
Poster presented at EHA2022 exploring the potential of PD-1 inhibition for relapsed/refractory (R/R) mature T- and NK-cell neoplasms.
Reading
26 maio 2022

v:vgmJ:!g9o! /Q~ a?l | 0Ty19Tr F2:azG}Pa}G@ 1=icNX}YrO= HZ?m]%`~?%L CFz]E f BE&kT ]jSR3nX_nXjC( ?K:[xFK? 5` 2N)bQ)K2 1F) M!ID!G ar@ k88cF_Fw =H qxYXWXxk;H9s ?3 M~$^)k$M ~dL- +rv$4vr2-+rS+$[Na+~ y,w,? Z%^HfM 7, W2m %jp,&|| _qr[eWi8i.

S!wDWD!g&0pV JUw ,HNN *ENrv7*rJ{ #;G/qK//( i3}(-c Vcc7QkQn !* 5v5 |OWX(: i? U8_ o?pXuzz 9f2IB8lwlz ^EEp [DDC P(W8zPf(}oW8 )X]fssfb*s _T[mD(pET[ET ,; rINLX\vIP X5c;|| %Qq^GQqhG ,:#:JTi.

E/dSu?_

[77KQ1oG sdh[6

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão